What is LLLT?
LLLT (Low Level Laser Therapy) is the application of red and near infra-red light over injuries or lesions to improve wound and soft tissue healing, reduce inflammation and give relief for both acute and chronic pain. First developed in 1967, it is now commonly referred to as LLLT.
LLLT is used to: increase the speed, quality and tensile strength of tissue repair; resolve inflammation and relieve pain (analgesia).
The red and near infrared light (600nm-1000nm) commonly used in LLLT can be produced by laser or high intensity LEDs. The intensity of LLLT lasers and LED's is not high like a surgical laser. There is no heating effect.
The effects of LLLT are photochemical (like photosynthesis in plants). When the correct intensity and treatment times are used, red and near infrared light reduces oxidative stress and increases ATP. This improves cell metabolism and reduce inflammation. These effects can be enhanced with pulses however when analgesia is required there is a second mechanism which works best when a strong continuous beam is applied.
LLLT devices are typically delivering 10mW - 500mW (0.01 -> 0.01 Watts). The power density typically ranges from 0.005W/Cm² -> 5 W/Cm².
LLLT is popularly used for soft tissue injuries, joint conditions, neuropathic pain, non-healing leg and pressure ulcers.
Introduction to LLLT Video
Introduction to LLLT and dose response by Prof. Michael Hamblin, Wellman Centre for Photomedicine, Harvard Medical School
Source: International Dose Response Society
This paper from Harvard Medical School reviews the LLLT mechanisms and the biphasic dose response. It summarises the molecular and cellular mechanisms of LLLT, gives a scientific explanation for the biphasic dose response (why a low dose has a stimulatory effect and why a high dose inhibits). Low power densities tend to get better healing and anti-inflammatory effects where higher power densities are more likely to inhibit (which may be useful if you just want an analgesic effect). I have to disclose an interest in this paper because I am a co-author. James Carroll CEO THOR Photomedicine.
» Available for free download here
PDF File Size: 4044KB - Link opens in new window
Product information and purchase enquiry
Sorry for the long form.
We are a global company and our computer needs to know who to direct your enquiry to.
* Mandatory field - this automatically directs your enquiry to the correct department
OUR CUSTOMERS INCLUDE:
The British Medical Journal (BMJ), The Lancet, the International Association for the Study of Pain (IASP), the World Health Organisation (WHO), the Multinational Association for Supportive Care in Cancer (MASCC), the European Society for Medical Oncology (ESMO)